Workflow
梦百合(603313) - 2024 Q1 - 季度财报
Healthcare Healthcare (SH:603313)2024-04-29 09:28

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,818,967,738.44, representing a year-on-year increase of 7.08%[5] - The net profit attributable to shareholders for the same period was CNY 19,822,857.37, reflecting an 18.18% increase year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 262.74% to CNY 18,975,624.85[5] - Total revenue for Q1 2024 reached ¥1,818,967,738.44, an increase of 7.1% compared to ¥1,698,777,486.14 in Q1 2023[22] - Net profit for Q1 2024 was ¥21,501,812.37, compared to ¥19,637,876.76 in Q1 2023, representing an increase of 9.5%[23] Cash Flow - The net cash flow from operating activities decreased by 31.46% to CNY 132,075,306.14, primarily due to increased cash payments for goods and services[8] - In Q1 2024, the cash inflow from operating activities was CNY 2,069,875,219.91, an increase of 14.2% compared to CNY 1,812,006,275.96 in Q1 2023[25] - The net cash flow from operating activities decreased to CNY 132,075,306.14 in Q1 2024, down 31.5% from CNY 192,692,648.06 in Q1 2023[26] - Cash outflow for purchasing goods and services was CNY 1,346,663,984.63, up 31.6% from CNY 1,023,163,176.39 in the same period last year[26] - The net cash flow from investing activities was -CNY 44,875,864.02 in Q1 2024, worsening from -CNY 22,595,342.46 in Q1 2023[26] - Cash inflow from financing activities totaled CNY 551,084,742.66, a decrease of 4.1% compared to CNY 574,678,066.53 in Q1 2023[26] - The net cash flow from financing activities was -CNY 214,430,471.32, slightly improved from -CNY 217,932,700.42 in the previous year[26] - The ending cash and cash equivalents balance was CNY 866,340,737.00, significantly higher than CNY 399,497,768.27 at the end of Q1 2023[26] - The company received CNY 83,900,000.00 from other financing activities, an increase from CNY 41,700,000.00 in Q1 2023[26] - The cash received from investment income was CNY 1,283,015.26, down from CNY 15,757,394.06 in the same quarter last year[26] - The company reported a decrease in tax refunds received, totaling CNY 47,578,029.09 compared to CNY 85,858,359.91 in Q1 2023[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 9,887,213,992.51, down 1.77% from the end of the previous year[6] - The company's total assets decreased to ¥9,887,213,992.51 from ¥10,065,654,294.85, a decline of 1.8% year-over-year[20] - Total liabilities decreased to ¥5,978,234,680.75 from ¥6,118,386,471.72, a reduction of 2.3%[20] - As of March 31, 2024, the company's total current assets amounted to approximately RMB 4.62 billion, a decrease of 2.05% from RMB 4.72 billion as of December 31, 2023[18] - The company reported a total non-current assets value of RMB 4.03 billion as of March 31, 2024[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,185[10] - The largest shareholder, Ni Zhanggen, holds 32.85% of the shares, with 87,850,000 shares pledged[10] - The total equity attributable to shareholders decreased to ¥3,866,389,845.25 from ¥3,884,222,977.21, a decline of 0.5%[20] Legal Matters - The company recognized an estimated liability of RMB 122.56 million related to ongoing litigation as of the reporting date[14] - The company is involved in a legal dispute with a minority shareholder regarding a buyback of equity valued at USD 3.12 million[12] - The company has continued its appeal in a litigation case with a revised judgment amounting to USD 18.51 million[14] Other Financial Metrics - The weighted average return on net assets was 0.51%, a decrease of 0.05 percentage points compared to the previous year[5] - Research and development expenses increased to ¥23,422,099.93 from ¥20,620,160.92, marking a rise of 8.7%[23] - The company reported a basic earnings per share of ¥0.03, consistent with the previous year[24] - Other comprehensive income showed a significant decline, with a net amount of -¥39,790,323.74 compared to -¥553,582.65 in the previous year[24]